Interleukin 17A Participates in Renal Inflammation Associated to Experimental and Human Hypertension

• Үндсэн зохиолчид: Macarena Orejudo (Зохиогч), Raul R. Rodrigues-Diez (Зохиогч), Raquel Rodrigues-Diez (Зохиогч), Ana Garcia-Redondo (Зохиогч), Laura Santos-Sánchez (Зохиогч), Javier Rández-Garbayo (Зохиогч), Pablo Cannata-Ortiz (Зохиогч), Adrian M. Ramos (Зохиогч), Alberto Ortiz (Зохиогч), Rafael Selgas (Зохиогч), Sergio Mezzano (Зохиогч), Carolina Lavoz (Зохиогч), Marta Ruiz-Ortega (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Frontiers Media S.A., 2019-09-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Hypertension is now considered as an inflammatory disease, and the kidney is a key end-organ target. Experimental and clinical studies suggest that interleukin 17A (IL-17A) is a promising therapeutic target in immune and chronic inflammatory diseases, including hypertension and kidney disease. Eleva...